BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25168922)

  • 21. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
    Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
    J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
    Wu QP; Xie FY; Meng QL; Mu YY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Golgi protein 73(GP73), a useful serum marker in liver diseases.
    Liu X; Wan X; Li Z; Lin C; Zhan Y; Lu X
    Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection.
    Cao Z; Li Z; Wang H; Liu Y; Xu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Cai W; Liu L; Bao S; Xie Q
    Liver Int; 2017 Nov; 37(11):1612-1621. PubMed ID: 28772348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
    Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
    Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
    Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
    Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
    Ali OM; El Amin HA; Sharkawy YL; Mohamed Ali AA; Kholef EFM; Elsewify WAE
    Int J Gen Med; 2020; 13():193-200. PubMed ID: 32547160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic value and clinical significance of the Golgi protein-73 in hepatocellular carcinoma].
    Shi QF; Pan XD; Zhang WG; Shao WF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):480-2. PubMed ID: 23627036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
    Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
    Xu WF; Fei YM; Zhou JK; Shen HJ; Chen XF; Lv QQ; Ding YY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):286-8. PubMed ID: 22097609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis.
    Eissa M; Awad S; Barakat S; Saleh A; Rozaik S
    Med J Armed Forces India; 2021 Jul; 77(3):331-336. PubMed ID: 34305287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
    Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y
    Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GP73 level in patients with chronic hepatitis B: Relationship with liver biopsy, levels of ALT, AST and HBV DNA.
    Atilla A; Taşkın MH; Kazak Z; Aydın S; Kılıç SS
    Indian J Pathol Microbiol; 2022; 65(1):55-58. PubMed ID: 35074966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retrospective observation of dynamic levels of serum Golgi protein 73 in patients prior to the onset of liver cancer].
    Chen JG; Lu WZ; Zhu YR; Zhang YH; Lu JH; Chen TY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):731-5. PubMed ID: 24246080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.